Literature DB >> 23012362

Identification of molecular switch regulating interactions of Janus kinase 3 with cytoskeletal proteins.

Jayshree Mishra1, Satya Sridhar Karanki, Narendra Kumar.   

Abstract

Janus kinase 3 (Jak3) is a nonreceptor tyrosine kinase expressed in both hematopoietic and nonhematopoietic cells. Although mutations that abrogate Jak3 functions cause different immunological disorders, its constitutive activation leads to various types of cancer. Previously, we demonstrated that Jak3 interacted with actin-binding protein villin, thereby facilitating cytoskeletal remodeling and wound repair. In this study, we characterize the structural determinants that regulate the interactions between Jak3 and cytoskeletal proteins of the villin/gelsolin family. Functional reconstitution of kinase activity by recombinant full-length (wt) Jak3 using Jak3-wt or villin/gelsolin-wt as substrate showed that Jak3 autophosphorylation was the rate-limiting step during interactions between Jak3 and cytoskeletal proteins. Determination of kinetic parameters showed that phosphorylated (P) Jak3-wt binds to P-villin-wt with a dissociation constant (K(d)) of 23 nM and a Hill's coefficient of 3.7. Pairwise binding between Jak3 mutants and P-villin-wt showed that the FERM domain of Jak3 was sufficient for binding to P-villin-wt with a K(d) of 40.0 nM. However, the SH2 domain of Jak3 prevented P-villin-wt from binding to the FERM domain of nonphosphorylated protein. We demonstrate that the intramolecular interaction between the FERM and SH2 domains of nonphosphorylated Jak3 prevented Jak3 from binding to villin and that tyrosine autophosphorylation of Jak3 at the SH2 domain decreased these intramolecular interactions and facilitated binding of the FERM domain to villin. Thus we demonstrate the molecular mechanism of interactions between Jak3 and cytoskeletal proteins where tyrosine phosphorylation of the SH2 domain acted as an intramolecular switch for the interactions between Jak3 and cytoskeletal proteins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23012362      PMCID: PMC3510836          DOI: 10.1074/jbc.C112.363507

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Computational and functional analysis of the putative SH2 domain in Janus Kinases.

Authors:  D Kampa; J Burnside
Journal:  Biochem Biophys Res Commun       Date:  2000-11-11       Impact factor: 3.575

2.  Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases.

Authors:  Y J Zhou; M Chen; N A Cusack; L H Kimmel; K S Magnuson; J G Boyd; W Lin; J L Roberts; A Lengi; R H Buckley; R L Geahlen; F Candotti; M Gadina; P S Changelian; J J O'Shea
Journal:  Mol Cell       Date:  2001-11       Impact factor: 17.970

3.  Association of villin with phosphatidylinositol 4,5-bisphosphate regulates the actin cytoskeleton.

Authors:  Narendra Kumar; Peilin Zhao; Alok Tomar; Charles A Galea; Seema Khurana
Journal:  J Biol Chem       Date:  2003-11-01       Impact factor: 5.157

Review 4.  From the structure to the function of villin, an actin-binding protein of the brush border.

Authors:  E Friederich; E Pringault; M Arpin; D Louvard
Journal:  Bioessays       Date:  1990-09       Impact factor: 4.345

Review 5.  Jaks and cytokine receptors--an intimate relationship.

Authors:  Claude Haan; Stephanie Kreis; Christiane Margue; Iris Behrmann
Journal:  Biochem Pharmacol       Date:  2006-04-27       Impact factor: 5.858

6.  Molecular mechanism of interleukin-2-induced mucosal homeostasis.

Authors:  Jayshree Mishra; Christopher M Waters; Narendra Kumar
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-23       Impact factor: 4.249

7.  Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases.

Authors:  T Takahashi; T Shirasawa
Journal:  FEBS Lett       Date:  1994-04-04       Impact factor: 4.124

8.  JAK3: expression and mapping to chromosome 19p12-13.1.

Authors:  M G Safford; M Levenstein; E Tsifrina; S Amin; A L Hawkins; C A Griffin; C I Civin; D Small
Journal:  Exp Hematol       Date:  1997-05       Impact factor: 3.084

9.  The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor.

Authors:  L J Huang; S N Constantinescu; H F Lodish
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

10.  Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID).

Authors:  P Macchi; A Villa; S Giliani; M G Sacco; A Frattini; F Porta; A G Ugazio; J A Johnston; F Candotti; J J O'Shea
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

View more
  13 in total

1.  Adapter protein Shc regulates Janus kinase 3 phosphorylation.

Authors:  Jayshree Mishra; Narendra Kumar
Journal:  J Biol Chem       Date:  2014-05-02       Impact factor: 5.157

2.  Chicken-Specific Kinome Analysis of Early Host Immune Signaling Pathways in the Cecum of Newly Hatched Chickens Infected With Salmonella enterica Serovar Enteritidis.

Authors:  Michael H Kogut; Kenneth J Genovese; J Allen Byrd; Christina L Swaggerty; Haiqi He; Yuhua Farnell; Ryan J Arsenault
Journal:  Front Cell Infect Microbiol       Date:  2022-06-30       Impact factor: 6.073

3.  Role of Janus kinase 3 in mucosal differentiation and predisposition to colitis.

Authors:  Jayshree Mishra; Raj K Verma; Gianfranco Alpini; Fanyin Meng; Narendra Kumar
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

4.  A GEF-to-phospholipase molecular switch caused by phosphatidic acid, Rac and JAK tyrosine kinase that explains leukocyte cell migration.

Authors:  Madhu Mahankali; Karen M Henkels; Julian Gomez-Cambronero
Journal:  J Cell Sci       Date:  2013-02-01       Impact factor: 5.285

5.  Role of Janus Kinase 3 in Predisposition to Obesity-associated Metabolic Syndrome.

Authors:  Jayshree Mishra; Raj K Verma; Gianfranco Alpini; Fanyin Meng; Narendra Kumar
Journal:  J Biol Chem       Date:  2015-10-08       Impact factor: 5.157

6.  Intestinal breast cancer resistance protein (BCRP) requires Janus kinase 3 activity for drug efflux and barrier functions in obesity.

Authors:  Jayshree Mishra; Randall Simonsen; Narendra Kumar
Journal:  J Biol Chem       Date:  2019-10-25       Impact factor: 5.157

7.  A case of aberrant CD8 T cell-restricted IL-7 signaling with a Janus kinase 3 defect-associated atypical severe combined immunodeficiency.

Authors:  Aaruni Khanolkar; Jeffrey D Wilks; Guorong Liu; Bridget M Simpson; Edward A Caparelli; Dawn A Kirschmann; Jenna Bergerson; Ramsay L Fuleihan
Journal:  Immunol Res       Date:  2020-02       Impact factor: 2.829

8.  Jak3 enables chemokine-dependent actin cytoskeleton reorganization by regulating cofilin and Rac/Rhoa GTPases activation.

Authors:  Xochitl Ambriz-Peña; Eduardo Alberto García-Zepeda; Isaura Meza; Gloria Soldevila
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

9.  Chicken-Specific Kinome Array Reveals that Salmonella enterica Serovar Enteritidis Modulates Host Immune Signaling Pathways in the Cecum to Establish a Persistence Infection.

Authors:  Michael H Kogut; Christina L Swaggerty; James Allen Byrd; Ramesh Selvaraj; Ryan J Arsenault
Journal:  Int J Mol Sci       Date:  2016-07-27       Impact factor: 5.923

10.  Janus kinase 3 regulates adherens junctions and epithelial mesenchymal transition through β-catenin.

Authors:  Jayshree Mishra; Jugal Kishore Das; Narendra Kumar
Journal:  J Biol Chem       Date:  2017-08-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.